Bioventus (BVS) Non-Current Deferred Tax Liability (2020 - 2026)
Bioventus filings provide 6 years of Non-Current Deferred Tax Liability readings, the most recent being $433000.0 for Q4 2025.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 23.23% to $433000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $433000.0, a 23.23% decrease, with the full-year FY2025 number at $433000.0, down 23.23% from a year prior.
- Non-Current Deferred Tax Liability hit $433000.0 in Q4 2025 for Bioventus, down from $786000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $159.3 million in Q4 2022 to a low of $351000.0 in Q2 2023.
- Median Non-Current Deferred Tax Liability over the past 5 years was $1.8 million (2022), compared with a mean of $36.7 million.
- Biggest five-year swings in Non-Current Deferred Tax Liability: skyrocketed 1674.27% in 2021 and later plummeted 99.7% in 2023.
- Bioventus' Non-Current Deferred Tax Liability stood at $59.7 million in 2021, then crashed by 96.23% to $2.2 million in 2022, then plummeted by 46.04% to $1.2 million in 2023, then plummeted by 53.5% to $564000.0 in 2024, then decreased by 23.23% to $433000.0 in 2025.
- The last three reported values for Non-Current Deferred Tax Liability were $433000.0 (Q4 2025), $786000.0 (Q3 2025), and $651000.0 (Q2 2025) per Business Quant data.